We are live on ! Find out more
JMPWA

JP Morgan Private Wealth Advisors Portfolio holdings

AUM $35B
1-Year Est. Return 24.26%
This Fund
S&P 500
This Quarter Est. Return
+8.67%
1 Year Est. Return
+24.26%
3 Year Est. Return
+44.77%
5 Year Est. Return
+86.56%
10 Year Est. Return
+266.4%
AUM
$22B
AUM Growth
+$2.83B
Cap. Flow
+$1.25B
Cap. Flow %
5.7%
Top 10 Hldgs %
21.26%
Holding
1,540
New
115
Increased
825
Reduced
443
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 14.83%
2 Financials 9.57%
3 Healthcare 8.91%
4 Industrials 6.11%
5 Consumer Discretionary 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KTB icon
1176
Kontoor Brands
KTB
$4.14B
$347K ﹤0.01%
8,253
-2,925
-26% -$110K
OGS icon
1177
ONE Gas
OGS
$5B
$347K ﹤0.01%
3,711
+453
+14% +$41.4K
SUN icon
1178
Sunoco
SUN
$13.8B
$347K ﹤0.01%
11,338
+93
+0.8% +$2.93K
STNE icon
1179
StoneCo
STNE
$2.42B
$345K ﹤0.01%
8,650
+200
+2% +$7.32K
WORK
1180
DELISTED
Slack Technologies, Inc.
WORK
$343K ﹤0.01%
15,238
-53,867
-78% -$1.2M
AYI icon
1181
Acuity Brands
AYI
$10.7B
$342K ﹤0.01%
2,478
+59
+2% +$7.58K
RBA icon
1182
RB Global
RBA
$16.6B
$342K ﹤0.01%
7,974
-55
-0.7% -$2.29K
VRSN icon
1183
VeriSign
VRSN
$26B
$341K ﹤0.01%
1,769
-323
-15% -$60.7K
BAH icon
1184
Booz Allen Hamilton
BAH
$9.45B
$339K ﹤0.01%
4,763
+1,104
+30% +$78.6K
SUPN icon
1185
Supernus Pharmaceuticals
SUPN
$2.73B
$339K ﹤0.01%
14,273
-803
-5% -$19.5K
SAGE
1186
DELISTED
Sage Therapeutics
SAGE
$338K ﹤0.01%
4,676
-131
-3% -$16.1K
PTCT icon
1187
PTC Therapeutics
PTCT
$6.15B
$337K ﹤0.01%
7,016
DRE
1188
DELISTED
Duke Realty Corp.
DRE
$337K ﹤0.01%
9,722
+3,793
+64% +$131K
LPLA icon
1189
LPL Financial
LPLA
$29.2B
$336K ﹤0.01%
3,639
+136
+4% +$11.7K
ROKU icon
1190
Roku
ROKU
$22.4B
$336K ﹤0.01%
2,508
-723
-22% -$99.4K
BKR icon
1191
Baker Hughes
BKR
$64.3B
$335K ﹤0.01%
+13,077
New +$297K
BWA icon
1192
BorgWarner
BWA
$14.2B
$335K ﹤0.01%
8,756
+642
+8% +$23.5K
IXUS icon
1193
iShares Core MSCI Total International Stock ETF
IXUS
$60.2B
$333K ﹤0.01%
5,380
+68
+1% +$4.08K
BKI
1194
DELISTED
Black Knight, Inc. Common Stock
BKI
$333K ﹤0.01%
5,165
+1,186
+30% +$73.4K
GNTX icon
1195
Gentex
GNTX
$5.04B
$332K ﹤0.01%
11,468
-128
-1% -$3.6K
TDY icon
1196
Teledyne Technologies
TDY
$31.6B
$332K ﹤0.01%
958
+162
+20% +$54.5K
SASR
1197
DELISTED
Sandy Spring Bancorp Inc
SASR
$332K ﹤0.01%
8,769
+326
+4% +$11.5K
ILF icon
1198
iShares Latin America 40 ETF
ILF
$3.73B
$331K ﹤0.01%
9,751
BPMC
1199
DELISTED
Blueprint Medicines
BPMC
$329K ﹤0.01%
4,102
+10
+0.2% +$749
IVOO icon
1200
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.92B
$328K ﹤0.01%
4,726

Similar funds

JP Morgan Private Wealth Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, JP Morgan Private Wealth Advisors held 1,540 positions worth $22B, up 15% from $19.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

JP Morgan Private Wealth Advisors deployed $1.25B of net new capital in Q4 2019, opening 115 new positions and adding to 825 existing holdings. Its largest new stake was Invesco S&P 500 Pure Value ETF: 170,846 shares worth $11.8M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $18.2M trimmed.

  • JP Morgan Private Wealth Advisors's largest Q4 2019 buy was Invesco S&P 500 Pure Value ETF: 170,846 shares worth $11.8M.
  • JP Morgan Private Wealth Advisors added most to Energy Transfer Partners in Q4 2019, an estimated $61.5M increase.
  • JP Morgan Private Wealth Advisors's biggest Q4 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $18.2M.
  • JP Morgan Private Wealth Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $19.4M.
  • JP Morgan Private Wealth Advisors's ten largest holdings make up 21% of its $22B portfolio in Q4 2019.
  • JP Morgan Private Wealth Advisors opened 115 new positions and closed 74 in Q4 2019.
  • JP Morgan Private Wealth Advisors's portfolio value rose 15% quarter-over-quarter to $22B.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.